FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39165611000001102: Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Dec 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1697121000001118 Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1697141000001111 Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Is a Belimumab 200mg/1ml solution for injection pre-filled disposable devices true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Is a Benlysta true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has specific active ingredient Belimumab true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 4 pre-filled disposable injection Has AMP True Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has AMP True Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start